Philip Tsai
Vermögen: 945 239 $ am 31.05.2026
Vermögen: 945 239 $ am 31.05.2026
Philip Tsai is Chief Technical Officer at Immunome, Inc. since 2024.
Dr. Tsai was Senior Vice President-Technical Development at Seagen, Inc. from 2021 to 2024.
Education includes graduate and doctorate degrees from California Institute of Technology and an undergraduate degree from the University of Illinois At Urbana–Champaign.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC. 0.04% | 19.12.2025 | 43’300 ( 0.04% ) | 945 239 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.06.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2024 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen